DOCETAXEL INJECTION 80MG/4ML (RTU) is a premium-quality Ready-to-Use (RTU) anti-cancer chemotherapy injection manufactured under stringent quality standards by Medizia Biotech. Docetaxel is widely prescribed for the treatment of breast cancer, non-small cell lung cancer (NSCLC), prostate cancer, gastric cancer, and head & neck cancer. The ready-to-use formulation helps reduce preparation time, improves dosing convenience, and supports efficient hospital administration.

Medizia Biotech is a trusted name in third party manufacturing of oncology injections in India, offering high-quality pharmaceutical manufacturing solutions for healthcare companies, hospitals, institutional buyers, exporters, and distributors. Our manufacturing facilities follow WHO-GMP and ISO quality standards, ensuring consistent product quality, regulatory compliance, and reliable supply.

We provide third party manufacturing, contract manufacturing, private label manufacturing, custom packaging, bulk manufacturing, and export services for oncology injectables. With advanced production capabilities, strict quality control, competitive pricing, ready stock availability, and flexible batch sizes, Medizia Biotech is the preferred partner for pharmaceutical businesses looking to expand their oncology portfolio.

Choose Medizia Biotech for reliable Docetaxel Injection 80mg/4ml (RTU) manufacturing, timely delivery, superior quality, and professional pharmaceutical manufacturing services across India and international markets.